Literature DB >> 11145645

Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state.

T O Cameron1, J R Cochran, B Yassine-Diab, R P Sékaly, L J Stern.   

Abstract

Class I MHC tetramers have proven to be invaluable tools for following and deciphering the CD8(+) T cell response, but the development of similar reagents for detection of CD4(+) T cells based on class II MHC proteins has been more difficult. We evaluated fluorescent streptavidin-based oligomers of HLA-DR1 for use as reagents to analyze Ag-specific human CD4(+) T cells. Staining was blocked at low temperatures and by drugs that disrupt microfilament formation and endocytosis. Cell-associated MHC oligomers were resistant to a surface stripping protocol and were observed by microscopy in intracellular compartments. This behavior indicates that detection of CD4(+) T cells using class II MHC oligomers can depend on an active cellular process in which T cells cluster and/or endocytose their Ag receptors. T cells of identical specificity but in different activation states varied greatly in their ability to be detected by class II MHC oligomers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145645     DOI: 10.4049/jimmunol.166.2.741

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model.

Authors:  J D Stone; J R Cochran; L J Stern
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  A robust method for production of MHC tetramers with small molecule fluorophores.

Authors:  Vasanthi Ramachandiran; Vitalii Grigoriev; Lan Lan; Eugene Ravkov; Suzanne A Mertens; John D Altman
Journal:  J Immunol Methods       Date:  2006-09-22       Impact factor: 2.303

Review 3.  Quantitative challenges in understanding ligand discrimination by alphabeta T cells.

Authors:  Ofer Feinerman; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Mol Immunol       Date:  2007-09-06       Impact factor: 4.407

Review 4.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

5.  Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

Authors:  Pauline Weder; Ton N M Schumacher; Hergen Spits; Rosalie M Luiten
Journal:  Results Immunol       Date:  2012-05-10

6.  Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.

Authors:  Philippe Guillaume; Danijel Dojcinovic; Immanuel F Luescher
Journal:  Cancer Immun       Date:  2009-09-25

7.  In situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Ting Jia; Christian Elowsky; Qingsheng Li; You Zhou; Jay Reddy
Journal:  J Vis Exp       Date:  2014-08-01       Impact factor: 1.355

8.  Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.

Authors:  Maha Ayyoub; Danijel Dojcinovic; Pascale Pignon; Isabelle Raimbaud; Julien Schmidt; Immanuel Luescher; Danila Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

9.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.